Skip to main content

Table 2 Use the expression levels of circPTPN22, CEA, and CA199 to distinguish gastric cancer patients from healthy donors

From: As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway

  SEN, % SPE, % ACCU, % PPV, % NPV, %
CircPTPN22 0.78 (93/120) 0.84 (87/104) 0.80 (180/224) 0.85 (93/110) 0.76 (87/114)
CEA 0.75 (90/120) 0.68 (71/104) 0.72 (161/224) 0.73 (90/123) 0.70 (71/101)
CA199 0.71 (85/120) 0.40 (42/104) 0.57 (127/224) 0.58 (85/147) 0.55 (42/77)
CircPTPN22 + CEA 0.82 (98/120) 0.81 (84/104) 0.81 (182/224) 0.83 (98/118) 0.72 (84/116)
CircPTPN22 + CEA + CA199 0.83 (99/120) 0.87 (90/104) 0.84 (189/224) 0.88 (99/113) 0.81 (90/111)